| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |